| 11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Androsterone+etiocholanolone | — |
| 11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Androsterone+etiocholanolone | — |
| 11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol | — |
| 11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol | — |
| 11-Deoxytetrahydrocortisol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol | — |
| 11-Deoxytetrahydrocortisol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol | — |
| 17-Hydroxyprogesterone+Androstenedione/Cortisol | — |
| 2-Hydroxyadipate/Creatinine | — |
| 2-Methyltyrosine/Creatinine | — |
| 2-Oxoadipate/Creatinine | — |
| 2,8-dihydroxyadenine/Creatinine | — |
| 27-Norcholestanehexol/Creatinine | — |
| 3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab | — |
| 3-Hydroxytrimethyl-L-lysine/Creatinine | — |
| 3-Hydroxytrimethyl-L-lysine/Trimethyllysine | — |
| 3,4-Dihydroxyphenylacetate/Creatinine | — |
| 4-Hydroxy-3-Methoxyphenyllactate/Creatinine | — |
| 5-Aminoimidazole-4-carboxamide/Creatinine | — |
| 5-beta-cholestane-3-alpha,7-alpha,12-alpha,23-tetrol/Creatinine | — |
| 5-beta-cholestane-3-alpha,7-alpha,12-alpha,24,25-pentol/Creatinine | — |
| 5-Hydroxyhexanoate/Creatinine | — |
| 5-Hydroxymethyluracil/Creatinine | — |
| 5-Hydroxytryptophan | — |
| 5,6-Dihydrouracil/Creatinine | — |
| 5,6-Dihydrouridine/Creatinine | — |
| 6-oxo-piperidine-2-carboxylate/Creatinine | — |
| 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine | — |
| 7-Isobiopterin/Creatinine | — |
| Abnormal lymphocytes/Leukocytes in Vitreous fluid | — |
| Abnormal Prion Protein | — |
| Acetylcholine receptor Ab | — |
| Acetylcholine receptor binding Ab | sourced |
| Acetylcholine receptor blocking Ab | — |
| Acetylcholine receptor modulation Ab/Acetylcholine Ab total | — |
| Acremonium sp IgE Ab | — |
| Actin IgG Ab | sourced |
| Acyl CoA dehydrogenases palmitate substrate/Acyl CoA dehydrogenases myristate substrate in Fibroblast | — |
| Adenine/Creatinine | — |
| Adenosine/Creatinine | — |
| Adenovirus IgG Ab | — |
| Adenovirus IgM Ab | — |
| Adulterants | — |
| Albumin renal clearance | — |
| Albumin/Albumin | — |
| Aldosterone/Renin | sourced |
| Alloisoleucine+Isoleucine+Leucine+Hydroxyproline+Valine/Phenylalanine+Tyrosine | — |
| Almond IgE Ab | — |
| Alpha 1 antitrypsin fecal clearance | — |
| Alpha-1-Fetoprotein Ag (Tissue, qualitative, immune stain) | — |
| Alternaria alternata IgE Ab | — |
| American Beech IgE Ab | — |
| American Cockroach IgE Ab | — |
| American house dust mite IgE Ab | — |
| American Sycamore IgE Ab | — |
| Amylase/Creatinine renal clearance and Serum or Plasma | — |
| Anaplasma phagocytophilum IgG Ab (immunofluorescence) | — |
| Anaplasma phagocytophilum IgM Ab (immunofluorescence) | — |
| Androsterone+etiocholanolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol | — |
| Androsterone+etiocholanolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol | — |
| APOE gene mutations found or Tissue | — |
| Apolipoprotein CIII-0/Apolipoprotein CIII-2 | — |
| Apolipoprotein CIII-1/Apolipoprotein CIII-2 | — |
| Appearance | — |
| Appearance | — |
| Appearance | — |
| Apple IgE Ab | — |
| aPTT | — |
| aPTT | — |
| aPTT | — |
| aPTT | — |
| aPTT | sourced |
| aPTT after addition of APC | — |
| aPTT factor substitution 1 hour post incubation | — |
| aPTT factor substitution 1 hour post incubation | — |
| aPTT factor substitution 1H post incubation with 1:1 normal plasma | — |
| aPTT factor substitution 1H post incubation with normal plasma | — |
| aPTT factor substitution immediately after 1:1 addition of normal plasma | — |
| aPTT factor substitution immediately after addition of normal plasma | — |
| aPTT lupus sensitive | — |
| aPTT lupus sensitive | — |
| aPTT lupus sensitive | — |
| aPTT lupus sensitive | — |
| aPTT lupus sensitive (LA screen) | — |
| aPTT lupus sensitive excess phospholipid post heparin neutralization | — |
| aPTT lupus sensitive excess phospholipid post heparin neutralization | — |
| aPTT lupus sensitive post heparin neutralization | — |
| aPTT lupus sensitive with 1:1 PNP | — |
| aPTT lupus sensitive with 1:1 PNP (LA mix) | — |
| aPTT lupus sensitive/aPTT lupus sensitive | sourced |
| aPTT saline 1:1 | — |
| Aquaporin 4 water channel Ab | — |
| Arabitol/Creatinine | — |
| Arachidonate (C20:4w6)/Eicosapentaenoate (C20:5w3) | — |
| Arachidonate (C20:4w6)+Linoleate (C18:2w6)/Fatty acids C14-C22 | — |
| Arachidonic acid | — |
| Aspergillus flavus Ab | — |
| Aspergillus fumigatus Ab | — |
| Aspergillus fumigatus IgE Ab | — |
| Aspergillus niger Ab | — |
| Aspergillus sp Ab (complement fixation) | — |
| Aspergillus sp Ab) | — |
| Aureobasidium pullulans IgE Ab | — |
| Australian pine IgE Ab | — |
| B-cell precursors (Bone Marrow, flow cytometry (fc)) | — |
| Babesia microti IgG Ab | — |
| Babesia microti IgM Ab | — |
| Bacterial versus viral infection likelihood | — |
| Bahia grass IgE Ab | — |
| Baker's yeast IgA Ab | sourced |
| Baker's yeast IgA Ab | — |
| Baker's yeast IgE Ab | — |
| Baker's yeast IgG Ab | — |
| Bald Cypress IgE Ab | — |
| Banana IgE Ab | — |
| Band form neutrophils/cells (Bone Marrow, manual count) | — |
| Band form neutrophils/Leukocytes in Pericardial fluid | — |
| Band form neutrophils/Leukocytes in Stem cell product | — |
| Barium (Hair) | — |
| Barley IgE Ab | — |
| Bartonella quintana IgG Ab | — |
| Bartonella quintana IgM Ab | — |
| Basophils band form/Leukocytes (Bone Marrow) | — |
| Basophils/cells (Bone Marrow, manual count) | — |
| Basophils/Leukocytes | — |
| Basophils/Leukocytes | — |
| Basophils/Leukocytes in Bronchial specimen | — |
| Basophils/Leukocytes in Stem cell product | — |
| Bayberry Pollen IgE Ab | — |
| Beclomethasone dipropionate | — |
| Beef IgE Ab | — |
| Bermuda grass IgE Ab | — |
| Beryllium (Hair) | — |
| Beta 2 glycoprotein 1 IgA Ab | — |
| Beta 2 glycoprotein 1 IgA Ab | sourced |
| Beta 2 glycoprotein 1 IgG Ab | — |
| Beta 2 glycoprotein 1 IgG Ab | sourced |
| Beta 2 glycoprotein 1 IgM Ab | — |
| Beta 2 glycoprotein 1 IgM Ab | sourced |
| Bilirubin total/Total in Stone (infrared spectroscopy) | — |
| BK virus DNA (viral load) | — |
| BK virus DNA (viral load) (naa with probe detection) | — |
| BK virus DNA (viral load) (naa with probe detection) | — |
| Blastomyces dermatitidis Ab | — |
| Blastomyces dermatitidis Ab (complement fixation) | — |
| Blastomyces dermatitidis Ag | — |
| Blasts/cells (Bone Marrow) | — |
| Blasts/Leukocytes in Pericardial fluid | — |
| Blasts/Leukocytes in Stem cell product | — |
| Blood group antibody screen | — |
| Body fld type | — |
| Bordetella pertussis IgG Ab | — |
| Borrelia burgdorferi Ab | — |
| Borrelia burgdorferi Ab | — |
| Borrelia burgdorferi Ab | — |
| Borrelia burgdorferi Ab | — |
| Borrelia burgdorferi IgG Ab | — |
| Borrelia burgdorferi IgG Ab | — |
| Borrelia burgdorferi IgG and IgM | — |
| Borrelia burgdorferi IgG and IgM (immunoblot) | — |
| Borrelia burgdorferi IgG+IgM Ab | — |
| Borrelia burgdorferi IgG+IgM Ab | — |
| Borrelia burgdorferi IgM Ab | — |
| Boxelder IgE Ab | — |
| Brazil Nut IgE Ab | — |
| Brome IgE Ab | — |
| Burr cells | — |
| Butyrylglycine/Creatinine | — |
| Butyrylglycine/Creatinine | — |
| Calcium bilirubinate/Total in Stone | — |
| Calcium carbonate/Total in Stone | — |
| Calcium hydrogen phosphate dihydrate crystals | — |
| Calcium hydrogen phosphate dihydrate crystals | — |
| Calcium hydrogen phosphate dihydrate crystals in Stone | — |
| Calcium hydrogen phosphate dihydrate/Total in Stone | — |
| Calcium magnesium phosphate/Total in Stone | — |
| Calcium oxalate crystals | — |
| Calcium oxalate dihydrate/Total in Stone | — |
| Calcium oxalate dihydrate/Total in Stone (infrared spectroscopy) | — |
| Calcium oxalate monohydrate/Total in Stone | — |
| Calcium oxalate/Total in Stone | — |
| Calcium phosphate/Total in Stone | — |
| Calcium-calmodulin-dependent protein kinase II activity | — |
| Calculus analysis in Stone | — |
| Calculus analysis in Stone Narrative (infrared spectroscopy) | — |
| California Live Oak IgE Ab | — |
| California Walnut IgE Ab | — |
| California Walnut Pollen IgE Ab | — |
| Canary grass IgE Ab | — |
| Candida albicans IgE Ab | — |
| Candida sp Ab) | — |
| Carboxyhemoglobin/Hemoglobin total | — |
| Carboxyhemoglobin/Hemoglobin total | — |
| Carboxyhemoglobin/Hemoglobin total | — |
| Carboxyhemoglobin/Hemoglobin total | — |
| Cardiolipin IgA Ab | — |
| Cardiolipin IgA Ab | sourced |
| Cardiolipin IgG Ab | — |
| Cardiolipin IgG Ab | — |
| Cardiolipin IgG Ab | sourced |
| Cardiolipin IgM Ab | — |
| Cardiolipin IgM Ab | — |
| Cardiolipin IgM Ab | sourced |
| Carnitine free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline | — |
| Carrot IgE Ab | — |
| Casein IgE Ab | — |
| Casein IgG Ab | — |
| Cashew nut IgE Ab | — |
| Cat dander IgE Ab | — |
| CD10 cells/cells | — |
| CD117 cells/cells | — |
| CD11b cells/cells | — |
| CD11c cells/cells | — |
| CD13 cells/cells | — |
| CD14 cells/cells | — |
| CD15 cells/cells | — |
| CD16+CD57+ cells/cells | — |
| CD1a cells/cells | — |
| CD22 cells/cells | — |
| CD23 cells/cells | — |
| CD235a cells/cells | — |
| CD3+ CD14+ CD19+CD20+ CD45+CD56+CD123+HLA-DR (flow cytometry (fc)) | — |
| CD3+CD11c+CD14+CD19+CD20+CD45+CD56+HLA-DR+ (flow cytometry (fc)) | — |
| CD33 cells/cells | — |
| CD38 cells/cells | — |
| CD41 cells/cells | — |
| CD41a cells/cells | — |
| CD45 (Lymphs) cells/cells | — |
| CD5 cells/cells | — |
| CD55 deficient Granulocytes/cells | — |
| CD55 deficient RBC/Erythrocytes | — |
| CD55+CD59 deficient RBC | — |
| CD55+CD59 RBC | — |
| CD59 deficient Granulocytes/cells | — |
| CD64 cells/cells | — |
| CD7 cells/cells | — |
| CD71 cells/cells | — |
| CD79a cells/cells | — |
| CD79b cells/cells | — |
| CEA | sourced |
| Centromere Ab | sourced |
| Centromere protein B Ab | — |
| Cerebroventricular lining cells/Leukocytes | — |
| CFTR gene mutations found | — |
| CFTR gene mutations found or Tissue | — |
| CFTR gene targeted mutation analysis or Tissue | — |
| Chenodeoxycholate+Cholate/Bile acid total | — |
| Chenodeoxycholate+Cholate/Bile acid total | — |
| Chestnut IgE Ab | — |
| Chicken droppings IgE Ab | — |
| Chicken feather IgE Ab | — |
| Chicken meat IgE Ab | — |
| Chlamydia trachomatis and Neisseria gonorrhoeae DNA | — |
| Chlamydia trachomatis DNA | — |
| Chlamydia trachomatis rRNA | — |
| Chocolate IgE Ab | — |
| Cholesterol total/Cholesterol in HDL | — |
| Cholesterol/Total in Stone | — |
| Cholinesterase fluoride inhibited/Cholinesterase | — |
| Chondroitin-6-sulfate/Creatinine | — |
| Chromatin Ab | sourced |
| Cladosporium herbarum IgE Ab | — |
| Cladosporium sphaerospermum IgE Ab | — |
| Clam IgE Ab | — |
| Clostridium tetani IgG Ab | — |
| Clostridium tetani IgG Ab | — |
| Coag tissue factor induced factor substitution 20M post incubation after addition of normal plasma | — |
| Coag tissue factor induced factor substitution 20M post incubation after addition of normal plasma | — |
| Coagulation surface induced lupus sensitive buffer (LA control) | — |
| Coccidioides immitis Ab (complement fixation) | — |
| Coccidioides immitis Ab) | — |
| Coccidioides immitis IgG Ab | sourced |
| Coccidioides immitis IgM Ab | sourced |
| Coccidioides sp Ab) | — |
| Cocklebur IgE Ab | — |
| Cockroach IgE Ab | — |
| Cockroach IgG Ab | — |
| Cocksfoot IgE Ab | — |
| Coconut IgE Ab | — |
| Codfish IgE Ab | — |
| Color | — |
| Color | — |
| Color | — |
| Color | — |
| Common pigweed IgE Ab | — |
| Common Ragweed IgE Ab | — |
| Common Sagebrush IgE Ab | — |
| Complement alternate pathway AH50 | — |
| Complement C1q Ab | — |
| Complement lectin pathway | — |
| Complement total hemolytic CH50 | — |
| Copper free | — |
| Corn IgE Ab | — |
| Corynebacterium diphtheriae Ab | sourced |
| Corynebacterium diphtheriae IgG Ab | — |
| Corynebacterium diphtheriae IgG Ab | — |
| Cottonwood IgE Ab | — |
| Cow milk IgE Ab | — |
| Cow milk IgG4 Ab | — |
| Cow whey IgE Ab | — |
| Coxiella burnetii phase 1 IgG Ab | — |
| Coxiella burnetii phase 2 IgG Ab | — |
| Coxsackievirus A10 Ab (complement fixation) | — |
| Coxsackievirus A16 Ab (complement fixation) | — |
| Coxsackievirus A2 Ab (complement fixation) | — |
| Coxsackievirus A4 Ab (complement fixation) | — |
| Coxsackievirus A7 Ab (complement fixation) | — |
| Coxsackievirus A9 Ab (complement fixation) | — |
| Coxsackievirus B1 Ab (complement fixation) | — |
| Coxsackievirus B1+B2+B3+B4+B5+B6 Ab | — |
| Coxsackievirus B2 Ab (complement fixation) | — |
| Coxsackievirus B3 Ab (complement fixation) | — |
| Coxsackievirus B4 Ab (complement fixation) | — |
| Coxsackievirus B5 Ab (complement fixation) | — |
| Coxsackievirus B6 Ab (complement fixation) | — |
| Crab IgE Ab | — |
| Creatinine peritoneal dialysis clearance | — |
| Creatinine peritoneal dialysis clearance/1 73 sq M | — |
| Creatinine renal clearance | — |
| Creatinine renal clearance | — |
| Creatinine renal clearance | — |
| Creatinine renal clearance and Serum or Plasma | — |
| Creatinine renal clearance in 4 hour Urine and Serum or Plasma | — |
| Creatinine renal clearance in 6 hour Urine and Serum or Plasma | — |
| Creatinine renal clearance in 8 hour Urine and Serum or Plasma | — |
| Creatinine renal clearance/1 73 sq M | — |
| Creatinine renal clearance/1 73 sq M | — |
| Creatinine renal clearance/1 73 sq M | — |
| Creatinine renal clearance/1 73 sq M and Serum or Plasma | — |
| Creatinine renal clearance/1 73 sq M in 4 hour Urine and Serum or Plasma | — |
| Creatinine renal clearance/1 73 sq M in 6 hour Urine and Serum or Plasma | — |
| Creatinine renal clearance/1 73 sq M in 8 hour Urine and Serum or Plasma | — |
| Cryoglobulin complement C3 | — |
| Cryoglobulin IgA | — |
| Cryoglobulin IgM | — |
| Cryptococcus sp Ag | — |
| Cryptococcus sp Ag | — |
| Cyclic citrullinated peptide Ab | sourced |
| Cyclic citrullinated peptide IgA+IgG Ab | — |
| Cyclic citrullinated peptide IgG Ab | sourced |
| Cytidine/Creatinine | — |
| Cytomegalovirus DNA | — |
| Cytomegalovirus DNA (viral load) (naa with probe detection) | — |
| Cytomegalovirus IgG Ab | sourced |
| Cytomegalovirus IgG Ab | — |
| Cytomegalovirus IgM Ab | — |
| Cytomegalovirus IgM Ab | — |
| Cytomegalovirus IgM Ab | — |
| Cytomegalovirus IgM Ab | — |
| Cytomegalovirus IgM Ab (immunofluorescence) | — |
| Cytosine/Creatinine | — |
| D-2-hydroxyglutarate/Creatinine | — |
| D-serine/Creatinine | — |
| Decadienediate/Creatinine | — |
| Decenedioate/Creatinine | — |
| Dengue virus IgG Ab | — |
| Dengue virus IgG and IgM | — |
| Dengue virus IgM Ab | — |
| Deoxyadenosine/Creatinine | — |
| Deoxyguanosine/Creatinine | — |
| Deoxyhemoglobin/Hemoglobin total | — |
| Deoxyinosine/Creatinine | — |
| Deoxyuridine/Creatinine | — |
| Dihydrothymine/Creatinine | — |
| Dimethylphosphatidyl ethanolamine/Surfactant total | — |
| DNA double strand Ab | — |
| DNA double strand Ab | sourced |
| DNA double strand Ab (immunofluorescence (if) crithidia luciliae) | — |
| DNA single strand IgG Ab | — |
| Docosahexaenoic acid | — |
| Docosapentaenic acid | — |
| Dodecanedioate/Creatinine | — |
| Dodecanedioate/Creatinine | — |
| Dog dander IgE Ab | — |
| Dog epithelium IgE Ab | — |
| Dog Fennel IgE Ab | — |
| dRVVT | — |
| dRVVT | — |
| dRVVT | — |
| dRVVT | — |
| dRVVT | sourced |
| dRVVT excess phospholipid post heparin neutralization | — |
| dRVVT excess phospholipid post heparin neutralization | — |
| dRVVT factor substitution immediately after 1:1 addition of normal plasma and heparin neutralization | — |
| dRVVT post heparin neutralization | — |
| dRVVT with 1:1 PNP | — |
| dRVVT with 1:1 PNP (LA mix) | sourced |
| dRVVT/dRVVT | sourced |
| Eastern White Pine IgE Ab | — |
| EGFR gene mutations found or Tissue | — |
| Egg white IgE Ab | — |
| Egg yolk IgE Ab | — |
| Ehrlichia chaffeensis IgG Ab | — |
| Ehrlichia chaffeensis IgM Ab | — |
| Eicosapentaenoate (C20:5w3)+Docosapentaenate (C22:5w3)+Docosahexaenoate (C22:6w3)/Fatty acids C14-C22 risk Qualitative | — |
| Eicosapentaenoic acid | — |
| Endomysium Ab | — |
| Endomysium IgA Ab | — |
| Endomysium IgA Ab | — |
| Endomysium IgA Ab (immunofluorescence) | — |
| Energy content | — |
| English plantain IgE Ab | — |
| Entamoeba histolytica IgG Ab | — |
| Eosinophils band form/cells (Bone Marrow, manual count) | — |
| Eosinophils/cells (Bone Marrow, manual count) | — |
| Eosinophils/cells (Bone Marrow) | — |
| Eosinophils/Leukocytes | — |
| Eosinophils/Leukocytes in Bronchial specimen | — |
| Eosinophils/Leukocytes in Bronchial specimen | — |
| Eosinophils/Leukocytes in Stem cell product | — |
| EPA+DPA+DHA | — |
| Epstein Barr virus capsid IgG Ab | sourced |
| Epstein Barr virus capsid IgG Ab | — |
| Epstein Barr virus capsid IgG Ab | — |
| Epstein Barr virus capsid IgG Ab | — |
| Epstein Barr virus capsid IgG Ab | — |
| Epstein Barr virus capsid IgG Ab (immunofluorescence) | — |
| Epstein Barr virus capsid IgM Ab | — |
| Epstein Barr virus capsid IgM Ab | — |
| Epstein Barr virus capsid IgM Ab | — |
| Epstein Barr virus capsid IgM Ab | — |
| Epstein Barr virus capsid IgM Ab (immunofluorescence) | — |
| Epstein Barr virus DNA | — |
| Epstein Barr virus DNA (viral load) | — |
| Epstein Barr virus early Ab (immunofluorescence) | — |
| Epstein Barr virus early IgG Ab | — |
| Epstein Barr virus early IgG Ab | sourced |
| Epstein Barr virus early IgM Ab | — |
| Epstein Barr virus nuclear Ab | — |
| Epstein Barr virus nuclear Ab | — |
| Epstein Barr virus nuclear Ab (immunofluorescence) | — |
| Epstein Barr virus nuclear IgG Ab | — |
| Epstein Barr virus nuclear IgG Ab | — |
| Epstein Barr virus nuclear IgG Ab | — |
| Epstein Barr virus nuclear IgG Ab | — |
| Erythrocyte distribution width | — |
| Erythrocyte distribution width | — |
| Erythrocyte morphology | — |
| Erythrocyte sedimentation rate | — |
| Erythrocyte sedimentation rate | sourced |
| Erythrocytes CD59 deficient/Erythrocytes | — |
| Erythrocytes hyperchromic/Erythrocytes | — |
| Erythrocytes hypochromic/Erythrocytes | — |
| Erythroid cells/cells (Bone Marrow, manual count) | — |
| Estimated Non-liquefied volume | — |
| Ethyl sulfate+Ethyl glucuronide | — |
| European house dust mite IgE Ab | — |
| F2 gene mutations found or Tissue | — |
| F5 gene mutations found or Tissue | — |
| False ragweed IgE Ab | — |
| Fat | — |
| Fat | — |
| Fat | — |
| Fifth most predominant hemoglobin | — |
| Firebush IgE Ab | — |
| FMC7 cells/cells | — |
| FMR1 gene targeted mutation analysis or Tissue | — |
| Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab | — |
| Fourth most predominant hemoglobin | — |
| Fractional oxyhemoglobin | — |
| Fractional oxyhemoglobin | — |
| Fractional oxyhemoglobin | — |
| Fractional oxyhemoglobin | — |
| Fractional oxyhemoglobin | — |
| Fusarium moniliforme IgE Ab | — |
| Galactomannan Ag | — |
| Galactomannan Ag | — |
| Galactomannan Ag | — |
| Galectin 3 | sourced |
| Gamma butyrobetaine/Creatinine | — |
| Gamma butyrobetaine/Trimethyllysine | — |
| Giardia lamblia+Cryptosporidium sp Ag | — |
| Gliadin Ab | — |
| Gliadin IgA Ab | — |
| Gliadin IgA Ab | — |
| Gliadin IgG Ab | — |
| Gliadin IgG Ab | sourced |
| Glial fibrillary acidic protein | — |
| Glial fibrillary acidic protein+Ubiquitin carboxyl-terminal hydrolase-L1 or Blood Qualitative | — |
| Glomerular basement membrane IgG Ab | — |
| Glucan 1,4 alpha glucosidase in Small intestine Tissue | — |
| Glucose measurements in range out of Total glucose measurements during reporting period | — |
| Glucose/Glucose plas | — |
| Glutamate decarboxylase 65 Ab | — |
| Glutamate decarboxylase 65 Ab | sourced |
| Gluten IgE Ab | — |
| Gluten IgG Ab | — |
| Goose feather IgE Ab | — |
| Goosefoot IgE Ab | — |
| Granulocytic cells/cells (Bone Marrow, manual count) | — |
| Grey Alder IgE Ab | — |
| Groundsel Tree IgE Ab | — |
| Guanidinoacetate methyltransferase deficiency newborn screen interpretation | — |
| Guanine/Creatinine | — |
| Guanosine/Creatinine | — |
| Gum-Tree IgE Ab | — |
| Haemophilus influenzae B IgG Ab | sourced |
| Hairy cells/Leukocytes (Bone Marrow) | — |
| Hazelnut IgE Ab | — |
| Hazelnut Pollen IgE Ab | — |
| HBA1 gene mutations found or Tissue | — |
| HbA1c | sourced |
| Helicobacter pylori Ab | — |
| Helicobacter pylori Ab | — |
| Helicobacter pylori IgA Ab | — |
| Helicobacter pylori IgA Ab | — |
| Helicobacter pylori IgG Ab | — |
| Helicobacter pylori IgG Ab | — |
| Helicobacter pylori IgG Ab | — |
| Helicobacter pylori IgG Ab | — |
| Helicobacter pylori IgM Ab | — |
| Helicobacter pylori in Stomach | — |
| Hematocrit | — |
| Hematocrit | — |
| Hematocrit | — |
| Hematocrit | — |
| Hematocrit | — |
| Hematocrit | — |
| Hematocrit | sourced |
| Hematocrit (impedance) | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin | — |
| Hemoglobin A/Hemoglobin total | — |
| Hemoglobin A1/Hemoglobin total | — |
| Hemoglobin A1c/Hemoglobin total | — |
| Hemoglobin A1c/Hemoglobin total | — |
| Hemoglobin A1c/Hemoglobin total | — |
| Hemoglobin A1c/Hemoglobin total | — |
| Hemoglobin A1c/Hemoglobin total standardized per IFCC-RMP for CDT | — |
| Hemoglobin Barts/Hemoglobin total | — |
| Hemoglobin C/Hemoglobin total | — |
| Hemoglobin D/Hemoglobin total | — |
| Hemoglobin D/Hemoglobin total (hplc) | — |
| Hemoglobin disorders newborn screen interpretation | — |
| Hemoglobin E/Hemoglobin total | — |
| Hemoglobin F/Hemoglobin total | — |
| Hemoglobin O - Arab/Hemoglobin total | — |
| Hemoglobin S/Hemoglobin total | — |
| Hemoglobins that can be presumptively identified based on available controls | — |
| Heparin induced platelet Ab | — |
| Hepatitis A virus Ab | — |
| Hepatitis A virus Ab | — |
| Hepatitis A virus IgM Ab | — |
| Hepatitis A virus IgM Ab | — |
| Hepatitis A virus IgM Ab | — |
| Hepatitis A virus IgM Ab | — |
| Hepatitis B virus core Ab | — |
| Hepatitis B virus core Ab | — |
| Hepatitis B virus core Ab from Donor | — |
| Hepatitis B virus core IgM Ab | — |
| Hepatitis B virus core IgM Ab | — |
| Hepatitis B virus core IgM Ab | — |
| Hepatitis B virus DNA | — |
| Hepatitis B virus DNA (viral load) (naa with probe detection) | — |
| Hepatitis B virus e Ab | — |
| Hepatitis B virus e Ag | — |
| Hepatitis B virus e Ag | — |
| Hepatitis B virus e Ag | — |
| Hepatitis B virus surface Ab | — |
| Hepatitis B virus surface Ab | — |
| Hepatitis B virus surface Ab | — |
| Hepatitis B virus surface Ab | — |
| Hepatitis B virus surface Ab) | — |
| Hepatitis B virus surface Ag | — |
| Hepatitis B virus surface Ag | — |
| Hepatitis B virus surface Ag | — |
| Hepatitis B virus surface Ag | — |
| Hepatitis B virus surface Ag from Donor | — |
| Hepatitis C virus Ab | — |
| Hepatitis C virus Ab | — |
| Hepatitis C virus Ab | — |
| Hepatitis C virus Ab | — |
| Hepatitis C virus Ab from Donor | — |
| Hepatitis C virus Ab Signal/Cutoff | — |
| Hepatitis C virus core Ag or Marrow from Donor | — |
| Hepatitis C virus genotype (naa with probe detection) | — |
| Hepatitis C virus RNA | — |
| Hepatitis C virus RNA (viral load) (naa with probe detection) | — |
| Hepatitis C virus RNA (viral load) (naa with probe detection) | — |
| Hepatitis C virus RNA (viral load) (naa with probe detection) | — |
| Hepatitis C virus RNA (viral load) (naa with probe detection) | — |
| Hepatitis D virus Ab | — |
| Herpes simplex virus 1 IgG Ab | — |
| Herpes simplex virus 1 IgG Ab | — |
| Herpes simplex virus 1 IgG Ab | — |
| Herpes simplex virus 1 IgM Ab (immunofluorescence) | — |
| Herpes simplex virus 1+2 DNA | — |
| Herpes simplex virus 1+2 IgG Ab | — |
| Herpes simplex virus 1+2 IgG Ab | sourced |
| Herpes simplex virus 1+2 IgM Ab | — |
| Herpes simplex virus 2 IgG Ab | — |
| Herpes simplex virus 2 IgG Ab | — |
| Herpes simplex virus 2 IgG Ab | — |
| Herpes simplex virus 2 IgM Ab (immunofluorescence) | — |
| Herpes simplex virus Ab | — |
| Herpes simplex virus IgM Ab | — |
| Herpes simplex virus IgM Ab | — |
| Herpes virus 6 IgG Ab | — |
| Heterophile Ab | — |
| Heterophile Ab | — |
| HEXA gene mutations found or Tissue | — |
| Hexadecanedioate/Creatinine | — |
| HFE gene mutations found or Tissue | — |
| HFE gene targeted mutation analysis or Tissue | — |
| Histone IgG Ab | sourced |
| Histoplasma capsulatum Ab) | — |
| Histoplasma capsulatum Ag | — |
| Histoplasma capsulatum Ag | — |
| Histoplasma capsulatum Ag | — |
| Histoplasma capsulatum Ag) | — |
| Histoplasma capsulatum M Ab | — |
| Histoplasma capsulatum mycelial phase Ab (complement fixation) | — |
| Histoplasma capsulatum mycelial phase Ab (immune diffusion (id)) | — |
| Histoplasma capsulatum yeast phase Ab (complement fixation) | — |
| HIV 1 RNA (viral load) | — |
| HIV 1 RNA (viral load) (probe with signal amplification) | — |
| HIV 1 RNA (viral load) (probe with signal amplification) | — |
| HIV 1+2 Ab | — |
| HIV 1+2 Ab | — |
| HIV 1+2 Ab | — |
| HIV 1+2 Ab | — |
| HIV 1+2 Ab from Donor | — |
| HIV 1+O+2 Ab | — |
| HIV 1+O+2 Ab | — |
| HIV 2 Ab | — |
| HIV 2 Ab | — |
| HIV genotype in Isolate (genotype method narrative) | — |
| HIV protease gene mutations detected | — |
| HLA-A+B+C (class I) Ab | — |
| HLA-DR+ cells/cells | — |
| Honey bee IgE Ab | — |
| Horse dander IgE Ab | — |
| House dust Greer IgE Ab | — |
| HP gene mutations found or Tissue | — |
| HTLV I+II Ab | — |
| HTLV I+II Ab | — |
| HTLV I+II Ab | — |
| HTLV I+II Ab from Donor | — |
| Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA in Cervix | — |
| Human papilloma virus 16 DNA in Cervix | — |
| Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA in Cervix | — |
| Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA in Cervix | — |
| Human papilloma virus 18 DNA in Cervix | — |
| Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA in Cervix | — |
| Human papilloma virus 6+11+42+43+44 DNA in Cervix | — |
| Human papilloma virus 6+11+42+43+44 DNA in Cervix | — |
| Hydroxyapatite crystals | — |
| IgG clearance/Albumin clearance and CSF | — |
| Influenza virus A and B Ag in Nose (rapid immunoassay) | — |
| Influenza virus A IgG Ab | — |
| Influenza virus A+B Ag | — |
| Influenza virus A+B Ag | — |
| Influenza virus A+B Ag | — |
| Influenza virus B Ag in Nasopharynx | — |
| Influenza virus B IgG Ab | — |
| Inosine/Creatinine | — |
| Inositol Free/Creatinine | — |
| Inositol Free/Creatinine in 5 hour Urine | — |
| INR | — |
| INR | — |
| Insulin Ab | — |
| Interferon beta | — |
| Intrinsic factor blocking Ab) | — |
| Invasive trophoblast Ag | — |
| Invasive trophoblast Ag | — |
| Iodinebush IgE Ab | — |
| Iothalamate renal clearance | — |
| Iothalamate renal clearance/Body surface area | — |
| Islet cell 512 Ab | — |
| Italian Cypress IgE Ab | — |
| Japanese Cedar IgE Ab | — |
| Jo-1 extractable nuclear Ab | — |
| Jo-1 extractable nuclear Ab | sourced |
| Johnson grass IgE Ab | — |
| Kappa lymphocytes/Lymphocytes | — |
| Kentucky blue grass IgE Ab | — |
| L-2-hydroxyglutarate/Creatinine | — |
| L-serine/Creatinine | — |
| Lactalbumin alpha IgE Ab | — |
| Lambda lymphocytes/Lymphocytes | — |
| Latex IgE Ab | — |
| Legionella pneumophila 1 Ag | — |
| Legionella pneumophila 1+2+3+4+5+6 IgM Ab | — |
| Legionella pneumophila Ab | — |
| Legionella pneumophila Ag | — |
| Legionella pneumophila Ag | — |
| Legionella pneumophila Ag | — |
| Legionella pneumophila Ag) | — |
| Lenscale IgE Ab | — |
| Leptospira sp Ab | — |
| Linoleic acid | — |
| Liver kidney microsomal 1 Ab | sourced |
| Liver kidney microsomal Ab (immunofluorescence) | — |
| Lobster IgE Ab | — |
| Locust tree IgE Ab | — |
| London Plane IgE Ab | — |
| Lymphoblasts/Leukocytes (Bone Marrow, manual count) | — |
| Lymphocyte subset or Tissue (molecular genetics method) | — |
| Lymphocytes/cells (Bone Marrow, manual count) | — |
| Lymphocytes/Leukocytes | — |
| Lymphocytes/Leukocytes | — |
| Lymphocytes/Leukocytes | — |
| Lymphocytes/Leukocytes in Bronchial specimen | — |
| Lymphocytes/Leukocytes in Bronchial specimen | — |
| Lymphocytes/Leukocytes in Stem cell product | — |
| Macadamia IgE Ab | — |
| Macroblasts/cells (Bone Marrow, manual count) | — |
| Macrophages/cells (Bone Marrow, manual count) | — |
| Macrophages/Leukocytes | — |
| Macrophages/Leukocytes (Bone Marrow, manual count) | — |
| Macrophages/Leukocytes in Bronchial specimen | — |
| Macrophages/Leukocytes in Bronchial specimen | — |
| Malate/Creatinine | — |
| Malignant cells/cells | — |
| Malignant cells/cells (Bone Marrow, manual count) | — |
| Malignant cells/cells (Bone Marrow) | — |
| Mango Pollen IgE Ab | — |
| Mannitol in 5 hour Urine | — |
| Mannose/Creatinine | — |
| Mast cells/cells (Bone Marrow, flow cytometry (fc)) | — |
| Mast cells/cells (Bone Marrow, manual count) | — |
| MCV | — |
| MCV | sourced |
| MCV | — |
| Measles virus IgG Ab | sourced |
| Measles virus IgG Ab | — |
| Measles virus IgG Ab | — |
| Megaloblasts/cells (Bone Marrow) | — |
| Mesothelial cells/Leukocytes | — |
| Mesquite IgE Ab | — |
| Metabolic disorder being monitored | — |
| Metachromatic leukodystrophy comment newborn screen interpretation | — |
| Metamyelocytes eosinophilic/cells (Bone Marrow, manual count) | — |
| Metamyelocytes neutrophilic/Leukocytes (Bone Marrow, manual count) | — |
| Metamyelocytes/cells (Bone Marrow, manual count) | — |
| Metamyelocytes/Leukocytes in Stem cell product | — |
| Methemoglobin/Hemoglobin total | — |
| Methemoglobin/Hemoglobin total | — |
| Methemoglobin/Hemoglobin total | — |
| Methemoglobin/Hemoglobin total | — |
| Methicillin resistant Staphylococcus aureus (MRSA) DNA | — |
| Mevalonate/Creatinine | — |
| Microalbumin | — |
| Microalbumin | — |
| Microalbumin ug/min | — |
| Microscopic observation | — |
| Microscopic observation | — |
| Microscopic observation | — |
| Microscopic observation | — |
| Microscopic observation | — |
| Microscopic observation in Cervical or vaginal smear or scraping (cyto stain) | — |
| Microscopic observation in Cervix (cyto stain thin prep) | — |
| Microscopic observation in Cervix (cyto stain) | — |
| Microscopic observation in Endocervical brush (cyto stain) | — |
| Milk IgE Ab | — |
| Mitochondria Ab | — |
| Mitochondria Ab (immunofluorescence) | — |
| Mitochondria M2 IgG Ab | sourced |
| Monoblasts/Leukocytes (Bone Marrow, manual count) | — |
| Monocytes/cells (Bone Marrow, manual count) | — |
| Monocytes/Leukocytes | — |
| Monocytes/Leukocytes in Stem cell product | — |
| Monocytes+Macrophages/Leukocytes | — |
| Mononuclear cells/Leukocytes in Stem cell product | — |
| Most predominant hemoglobin | — |
| Mountain Juniper IgE Ab | — |
| MPV | sourced |
| MTHFR gene mutations found or Tissue | — |
| MTHFR gene targeted mutation analysis or Tissue | — |
| Mucor racemosus IgE Ab | — |
| Mugwort IgE Ab | — |
| Mumps virus IgG Ab | sourced |
| Mumps virus IgG Ab | — |
| Mumps virus IgG Ab | — |
| Mumps virus IgG Ab | — |
| Mumps virus IgM Ab | — |
| Mycoplasma hominis DNA | — |
| Mycoplasma pneumoniae IgG Ab | sourced |
| Mycoplasma pneumoniae IgM Ab | sourced |
| Myeloblasts/cells (Bone Marrow, manual count) | — |
| Myelocytes eosinophilic/cells (Bone Marrow, manual count) | — |
| Myelocytes neutrophilic/cells (Bone Marrow, manual count) | — |
| Myelocytes/cells (Bone Marrow, manual count) | — |
| Myelocytes/Leukocytes in Stem cell product | — |
| Myeloid cells/cells (Bone Marrow, manual count) | — |
| Myeloid cells/Erythroid cells (Bone Marrow) | — |
| Myeloperoxidase Ab | — |
| Myeloperoxidase Ab | sourced |
| Myeloperoxidase cells/cells | — |
| N-acetyl-L-alanine/Creatinine | — |
| N-acetyl-L-glutamate/Creatinine | — |
| N-acetyl-L-methionine/Creatinine | — |
| N-acetylglycine/Creatinine | — |
| N-acetylglycine/Creatinine | — |
| N-carbamoyl beta alanine/Creatinine | — |
| N-octanoylglycine/Creatinine | — |
| Natural killer cell cytotoxicity 0 9:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity 1 88:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity 100:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity 12 5:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity 15:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity 25:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity 3 13:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity 3 75:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity 30:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity 50:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity 6 25:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity 7 5:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity IL-2 stimulated 30:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity IL-stimulated 0 9:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity IL-stimulated 1 88:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity IL-stimulated 15:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity IL-stimulated 3 75:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Natural killer cell cytotoxicity IL-stimulated 7 5:1 effector to target cell ratio/Positive control mononuclear cells | — |
| Neisseria gonorrhoeae DNA | — |
| Neisseria gonorrhoeae rRNA | — |
| Nettle IgE Ab | — |
| Neutrophil Ab) | — |
| Neutrophil cytoplasmic Ab | — |
| Neutrophil fMLP stimulated DHR/Neutrophil fMLP stimulated total (flow cytometry (fc)) | — |
| Neutrophil fMLP stimulated DHR/Neutrophil fMLP stimulated total in Control Blood (flow cytometry (fc)) | — |
| Neutrophil PMA stimulated DHR/Neutrophil PMA stimulated total (flow cytometry (fc)) | — |
| Neutrophil PMA stimulated DHR/Neutrophil PMA stimulated total in Control Blood (flow cytometry (fc)) | — |
| Neutrophils/cells (Bone Marrow, manual count) | — |
| Neutrophils/Leukocytes | — |
| Neutrophils/Leukocytes | — |
| Neutrophils/Leukocytes in Bronchial specimen | — |
| Neutrophils/Leukocytes in Bronchial specimen | — |
| Newberyite/Total in Stone | — |
| Normoblasts Basophilic/cells (Bone Marrow, manual count) | — |
| Normoblasts Orthochromic/cells (Bone Marrow, manual count) | — |
| Normoblasts Polychromatophilic/cells (Bone Marrow, manual count) | — |
| Normoblasts/cells (Bone Marrow, manual count) | — |
| Nuclear Ab | — |
| Nuclear Ab | — |
| Nuclear Ab | — |
| Nuclear Ab | — |
| Nuclear Ab | — |
| Nuclear Ab (immunofluorescence) | — |
| Nucleated erythrocytes/cells (Bone Marrow, manual count) | — |
| Nucleated erythrocytes/Leukocytes in Stem cell product | — |
| Number of occult blood specimens recommended (testing kit protocol | — |
| Oat IgE Ab | — |
| Oat pollen IgE Ab | — |
| Octanoate (C8:0)/Creatinine | — |
| Octenedioate (C8:1)/Creatinine | — |
| Olive Pollen IgE Ab | — |
| Omega 6 fatty acids (w6)/Omega 3 fatty acids (w3) | — |
| Omega-3 (EPA+DHA) index | — |
| Omega-3 (EPA+DHA) index risk | — |
| Orange IgE Ab | — |
| Osmolality | sourced |
| Osmolality | sourced |
| Osmolality | sourced |
| Osteoblasts/cells (Bone Marrow, manual) | — |
| Other cells/cells (Bone Marrow) | — |
| Other cells/Leukocytes | — |
| Other cells/Leukocytes in Stem cell product | — |
| Oxidants | — |
| Oxipurinol/Creatinine | — |
| Oyster IgE Ab | — |
| Pancreatic islet cell IgG Ab (immunofluorescence) | — |
| Para aminohippurate renal clearance/1 73 sq M and Serum or Plasma | — |
| Parietal cell Ab | — |
| Parietal cell Ab (immunofluorescence) | — |
| Parvovirus B19 IgG Ab | — |
| Parvovirus B19 IgG Ab | — |
| Parvovirus B19 IgG Ab | — |
| Parvovirus B19 IgG Ab | — |
| Parvovirus B19 IgG Ab | — |
| Parvovirus B19 IgM Ab | — |
| Parvovirus B19 IgM Ab | — |
| Parvovirus B19 IgM Ab | — |
| Parvovirus B19 IgM Ab | — |
| Parvovirus B19 IgM Ab | sourced |
| Pea IgE Ab | — |
| Peanut IgE Ab | — |
| Pecan or Hickory Nut IgE Ab | — |
| Pecan or Hickory Tree IgE Ab | — |
| Pellitory (Parietaria officinalis) IgE Ab | — |
| Penicillin G IgE Ab | — |
| Penicillium notatum IgE Ab | — |
| Pepsin A+Pepsinogen A in Lower respiratory specimen | — |
| Perennial rye grass IgE Ab | — |
| Phosphatidylcholine/Albumin | — |
| Phosphatidylethanolamine/Surfactants total | — |
| Phosphatidylinositol+Phosphatidylserine/Surfactant total | — |
| Phosphatidylserine IgA Ab | — |
| Phosphatidylserine IgA Ab | — |
| Phosphatidylserine IgA Ab | sourced |
| Phosphatidylserine IgG Ab | — |
| Phosphatidylserine IgG Ab | — |
| Phosphatidylserine IgG Ab | — |
| Phosphatidylserine IgG Ab | sourced |
| Phosphatidylserine IgM Ab | — |
| Phosphatidylserine IgM Ab | — |
| Phosphatidylserine IgM Ab | — |
| Phosphatidylserine IgM Ab | sourced |
| Phosphatidylserine-prothrombin complex IgG Ab | — |
| Phosphatidylserine-prothrombin complex IgM Ab | — |
| Phospholipid IgA Ab | sourced |
| Phospholipid IgG Ab | — |
| Phospholipid IgM Ab | — |
| Phosphorus reabsorbed | — |
| Pigeon serum Ab) | — |
| Pine Nut IgE Ab | — |
| Pistachio IgE Ab | — |
| Platelet mean volume | — |
| Platelet mean volume | — |
| Pork IgE Ab | — |
| Post-discharge provider ID | — |
| Post-discharge provider name in Provider | — |
| Post-discharge provider practice address | — |
| Post-discharge provider practice ID | — |
| Post-discharge provider practice name | — |
| Potato IgE Ab | — |
| Predominant leukocyte identified in Ear | — |
| Pregnanediolone/Creatinine | — |
| Pregnanediolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol | — |
| Pregnanediolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol | — |
| Prenanediolone+pregnanetriol/Androsterone+etiocholanolone | — |
| Prenanediolone+pregnanetriol/Androsterone+etiocholanolone | — |
| Prenanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol | — |
| Prenanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol | — |
| Previous fetus defect | — |
| Privet IgE Ab | — |
| Prolymphocytes/cells (Bone Marrow, manual count) | — |
| Promonocytes/cells (Bone Marrow, manual count) | — |
| Promyelocytes/cells (Bone Marrow, manual count) | — |
| Promyelocytes/Leukocytes in Stem cell product | — |
| Pronormoblasts/cells (Bone Marrow, manual count) | — |
| Pronormoblasts/cells (Bone Marrow) | — |
| Prostate specific Ag | — |
| Prostate specific Ag | — |
| Prothrombin time (PT) | — |
| Prothrombin time (PT) | — |
| Prothrombin time (PT) | sourced |
| Prothrombin time (PT) factor substitution 1 hours post incubation | — |
| Prothrombin time (PT) factor substitution 1H post incubation with 1:4 normal plasma | — |
| Prothrombin time (PT) factor substitution 1H post incubation with 1:4 normal plasma | — |
| Prothrombin time (PT) factor substitution 1H post incubation with normal plasma | — |
| Prothrombin time (PT) factor substitution 1H post incubation with normal plasma | — |
| Prothrombin time (PT) factor substitution 2 hours post incubation | — |
| Prothrombin time (PT) factor substitution 2H post incubation with 1:4 normal plasma | — |
| Prothrombin time (PT) factor substitution 2H post incubation with 1:4 normal plasma | — |
| Prothrombin time (PT) factor substitution 2H post incubation with normal plasma | — |
| Prothrombin time (PT) factor substitution 2H post incubation with normal plasma | — |
| Prothrombin time (PT) factor substitution immediately after 1:4 addition of normal plasma | — |
| Prothrombin time (PT) factor substitution immediately after 1:4 addition of normal plasma | — |
| Prothrombin time (PT) factor substitution immediately after addition of normal plasma | — |
| Prothrombin time (PT) factor substitution immediately after addition of normal plasma | — |
| Prothrombin time (PT) factor substitution with 1:4 normal plasma 1H post incubation separate tubes | — |
| Prothrombin time (PT) factor substitution with normal plasma 1H post incubation separate tubes | — |
| PSA | sourced |
| Pseudouridine/Creatinine | — |
| Queen Palm IgE Ab | — |
| R-beta aminoisobutyrate/Creatinine | — |
| Rabbit Bush IgE Ab | — |
| Ragocytes/Leukocytes | — |
| RDW | sourced |
| Reagin Ab | — |
| Reagin Ab | — |
| Reagin Ab | — |
| Reagin Ab | — |
| Reagin Ab (rpr) | — |
| Reagin Ab from Donor | — |
| Red Cedar IgE Ab | — |
| Red Maple IgE Ab | — |
| Red mulberry IgE Ab | — |
| Red top grass IgE Ab | — |
| Redwood IgE Ab | — |
| Reptilase time | — |
| Reptilase time | sourced |
| Reticulin Ab | — |
| Reticulocytes aggregate/Erythrocytes | — |
| Reticulocytes punctate/Erythrocytes | — |
| Reticulum cell/cells (Bone Marrow, gomori stain) | — |
| Rheumatoid arthritis nuclear Ab | — |
| Ribitol/Creatinine | — |
| Ribonucleoprotein extractable nuclear Ab | — |
| Ribonucleoprotein extractable nuclear Ab | — |
| Ribonucleoprotein extractable nuclear Ab | sourced |
| Ribonucleoprotein extractable nuclear Ab | — |
| Rice IgE Ab | — |
| Rickettsia rickettsii IgG Ab | — |
| Rickettsia rickettsii IgM Ab | — |
| Risankizumab Ab | — |
| Risk of ovarian malignancy algorithm score | — |
| Risk of ovarian malignancy algorithm score | — |
| Rough Marsh Elder IgE Ab | — |
| Rubella virus IgG Ab | — |
| Russian olive IgE Ab | — |
| S-beta aminoisobutyrate/Creatinine | — |
| Saccharopolyspora rectivirgula Ab | — |
| Salmon IgE Ab | — |
| Saltbush IgE Ab | — |
| Saltwort IgE Ab | — |
| Scallop IgE Ab | — |
| Schistosoma sp IgG Ab | — |
| SCL-70 extractable nuclear Ab | — |
| SCL-70 extractable nuclear Ab | sourced |
| Second most predominant hemoglobin | — |
| Sedoheptulose/Creatinine | — |
| Segmented neutrophils/cells (Bone Marrow) | — |
| Segmented neutrophils/Leukocytes (Bone Marrow, manual count) | — |
| Segmented neutrophils/Leukocytes in Pericardial fluid | — |
| Segmented neutrophils/Leukocytes in Stem cell product | — |
| Sepiapterin/Creatinine | — |
| Sesame Seed IgE Ab | — |
| Setomelanomma rostrata IgE Ab | — |
| Sheep Sorrel IgE Ab | — |
| Shrimp IgE Ab | — |
| Sialate free/Creatinine | — |
| Sialate free/Sialate total | — |
| Sialate total/Creatinine | — |
| Siderocytes Type 1/Erythroblasts or Marrow (prussian blue stain) | — |
| Siderocytes Type 2/Erythroblasts or Marrow (prussian blue stain) | — |
| Siderocytes Type 3/Erythroblasts or Marrow (prussian blue stain) | — |
| Silver Birch IgE Ab | — |
| Sjogrens syndrome-A extractable nuclear Ab | — |
| Sjogrens syndrome-A extractable nuclear Ab | — |
| Sjogrens syndrome-A extractable nuclear Ab | — |
| Sjogrens syndrome-A extractable nuclear Ab) | — |
| Sjogrens syndrome-B extractable nuclear Ab | — |
| Sjogrens syndrome-B extractable nuclear Ab | — |
| Sjogrens syndrome-B extractable nuclear Ab | — |
| Sjogrens syndrome-B extractable nuclear Ab) | — |
| Slender Ragweed IgE Ab | — |
| Smith extractable nuclear Ab | — |
| Smith extractable nuclear Ab | — |
| Smith extractable nuclear Ab | — |
| Smith extractable nuclear Ab) | — |
| Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab | — |
| Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab | — |
| SMN1 gene mutations found or Tissue | — |
| Smooth muscle Ab | — |
| Smooth muscle Ab | — |
| Smooth muscle Ab (immunofluorescence) | — |
| Sodium urate crystals | — |
| Sodium Urate crystals | — |
| Sodium urate/Total in Stone (infrared spectroscopy) | — |
| Soluble liver IgG Ab | sourced |
| Sorbitol/Creatinine | — |
| Soybean IgE Ab | sourced |
| Specific gravity | — |
| Specific gravity | — |
| Specific gravity | sourced |
| Specimen collection | — |
| Specimen collection | — |
| Spermatozoa Progressive Grade 1+2/Spermatozoa | — |
| Sphingomyelin/Surfactant total | — |
| Spruce IgE Ab | — |
| State printed on filter paper card in NBS card | — |
| Stemphylium botryosum IgE Ab | — |
| Strawberry IgE Ab | — |
| Streptococcus pneumoniae Ag | — |
| Streptolysin O Ab | sourced |
| Streptolysin O Ab | sourced |
| Strongyloides sp IgG Ab | sourced |
| Succinyladenosine/Creatinine | — |
| Surgical pathology study | — |
| Sweet gum IgE Ab | — |
| Terminal deoxyribonucleotidyl transferase cells/cells | — |
| Tetradecanedioate/Creatinine | — |
| Tetrahydrocortisol+5-alpha tetrahydrocortisol/Tetrahydrocortisone | — |
| Tetrahydrocortisol+5-alpha tetrahydrocortisol/Tetrahydrocortisone | — |
| Tetrahydrocortisone | — |
| Tetrahydrocortisone/Creatinine | — |
| Third most predominant hemoglobin | — |
| Threitol/Creatinine | — |
| Thrombin antithrombin complex Ag | — |
| Thrombin time | — |
| Thrombin time | sourced |
| Thrombin time factor substitution immediately after addition of bovine thrombin | — |
| Thymidine/Creatinine | — |
| Thymine/Creatinine | — |
| Thyroglobulin Ab | — |
| Thyroglobulin Ab | — |
| Thyroglobulin Ab | sourced |
| Thyroperoxidase Ab | sourced |
| Thyroperoxidase Ab | sourced |
| Thyrotropin receptor Ab | sourced |
| Timothy IgE Ab | — |
| Tissue transglutaminase IgA Ab | sourced |
| Tissue transglutaminase IgA Ab | — |
| Tissue transglutaminase IgA Ab | — |
| Tissue transglutaminase IgA Ab | sourced |
| Tissue transglutaminase IgG Ab | sourced |
| Tissue transglutaminase IgG Ab | — |
| Tissue transglutaminase IgG Ab | sourced |
| Tomato IgE Ab | — |
| Toxoplasma gondii IgG Ab | — |
| Toxoplasma gondii IgG Ab | sourced |
| Toxoplasma gondii IgM Ab | — |
| Toxoplasma gondii IgM Ab | sourced |
| TPMT gene targeted mutation analysis or Tissue | — |
| Trans-cinnamoylglycine/Creatinine | — |
| Transferrin carbohydrate deficient asialo/Transferrin carbohydrate deficient tetrasialo | sourced |
| Transferrin carbohydrate deficient disialo/Transferrin carbohydrate deficient tetrasialo | — |
| Transferrin carbohydrate deficient trisialo/Transferrin carbohydrate deficient tetrasialo | — |
| Treponema pallidum Ab | — |
| Treponema pallidum Ab | — |
| Treponema pallidum Ab | — |
| Treponema pallidum Ab | — |
| Treponema pallidum IgG Ab | — |
| Treponema pallidum IgG Ab | — |
| Treponema pallidum IgG Ab | sourced |
| Trienoate (C20:3w9)/Arachidonate (C20:4w6) | sourced |
| Trimethyllysine/Creatinine | — |
| Triple phosphate/Total in Stone | — |
| Trisomy 18 risk cutoff in Fetus | — |
| Trisomy 21 risk cutoff in Fetus | — |
| Tubular reabsorption of phosphorus/Glomerular filtration rate and Serum or Plasma | — |
| Tuna IgE Ab | — |
| Tungsten (Hair) | — |
| Ubiquitin carboxyl-terminal hydrolase-L1 | — |
| Unidentified cells/cells (Bone Marrow) | — |
| Urate crystals | — |
| Urate crystals | — |
| Urate dihydrate/Total in Stone | — |
| Uridine/Creatinine | — |
| Variant lymphocytes/cells (Bone Marrow, manual count) | — |
| Variant lymphocytes/Leukocytes in Pericardial fluid | — |
| Variant lymphocytes/Leukocytes in Stem cell product | — |
| Varicella zoster virus Ab | — |
| Varicella zoster virus IgG Ab | — |
| Varicella zoster virus IgG Ab | — |
| Varicella zoster virus IgG Ab | — |
| Varicella zoster virus IgG Ab | sourced |
| Varicella zoster virus IgM Ab | sourced |
| Vendor device model code of Glucose meter | — |
| Vendor name | — |
| Virginia Live Oak IgE Ab | — |
| von Willebrand factor (vWf) | sourced |
| von Willebrand factor (vWf) activity | — |
| von Willebrand factor (vWf) Ag | — |
| von Willebrand factor (vWf) Ag | sourced |
| Walnut IgE Ab | — |
| Wattle IgE Ab | — |
| West Nile virus RNA | — |
| Western Ragweed IgE Ab | — |
| Wheat IgE Ab | — |
| White Ash IgE Ab | — |
| White Birch IgE Ab | — |
| White Elm IgE Ab | — |
| White Elm IgG Ab | — |
| White Hickory IgE Ab | — |
| White mulberry IgE Ab | — |
| White Oak IgE Ab | — |
| Whole Egg IgE Ab | — |
| Wingscale IgE Ab | — |
| Wormwood IgE Ab | — |
| Xanthine/Total in Stone | — |
| Xanthopterin/Creatinine | — |
| XXX microorganism Ag | — |
| XXX microorganism DNA | — |
| Yellow Dock IgE Ab | — |
| Zinc transporter 8 Ab | sourced |
| Zirconium (Hair) | — |